Form 8-K · Current report
IDEX Corporation 8-K, filed Oct 28, 2026
- Filed
- CIK
- 0000832101
- Accession no.
- 0000832101-26-000026
Summary
IDEX Corporation reported record third-quarter 2026 results, with net sales of $952 million up 8% on both a reported and organic basis and adjusted diluted EPS of $2.33, up 15%, while orders rose 13% to $991 million. CEO Eric D. Ashleman attributed the performance to advantaged markets and larger acquired businesses, and the company raised its full-year guidance to organic sales growth of 6.5% to 6.8% and adjusted diluted EPS of $8.91 to $8.96.
Key points
- Net sales of $951.7 million rose 8% from $878.7 million a year earlier, with gross margin at 45.1%, up 60 basis points.
- Orders of $991.2 million increased 13%, including 13% organic growth.
- The Health & Science Technologies segment posted net sales of $433.5 million, up 14% reported and 13% organic, driven by AI-driven demand for data center power and semiconductor markets.
- IDEX returned $129 million to shareholders through dividends and share repurchases and amended its $800 million revolving credit facility to extend maturity to September 2031.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 – Results of Operations and Financial Condition. On October 28, 2026, IDEX Corporation (the “Company”) issued a press release announcing financial results for the period ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report. The information contained in this Item 2.02 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.